BioDivide is a leader in regenerative medicines, tools, technologies and services. Based in the Southwest UK, the Company combines extensive knowledge and expertise of the therapeutic applications of stem cells. BioDivide offers biomedical research capabilities to undertake stem cell research and brings regenerative medicine to patients quickly and efficiently. The Company’s lead product, StemPlan, is a stem cell therapy approved by the UK Veterinary Medicine’s Directorate that uses a non-invasive method of collecting stem cells for the treatment of equine patients. StemPlan provides assurance & peace of mind to horse owners.
BioDivide is a proud member of the United Kingdom’s Biotechnology Industry Association (BIA) and the Oxford Biotechnology Network (OBN).